Novel Therapeutic Strategy Based on Genetic and Epigenetic Abnormalities for Myeloid Neoplasms

Overview

Journal Int J Clin Oncol

Specialty Oncology

Date 2019 May 20

PMID 31104174

Authors

Takahiro Yamauchi

Affiliations

Soon will be listed here.

References

Pollyea D . New drugs for acute myeloid leukemia inspired by genomics and when to use them. Hematology Am Soc Hematol Educ Program. 2018; 2018(1):45-50. PMC: 6245963. DOI: 10.1182/asheducation-2018.1.45. View

Tiu R, Visconte V, Traina F, Schwandt A, Maciejewski J . Updates in cytogenetics and molecular markers in MDS. Curr Hematol Malig Rep. 2011; 6(2):126-35. DOI: 10.1007/s11899-011-0081-2. View

Steensma D . How I use molecular genetic tests to evaluate patients who have or may have myelodysplastic syndromes. Blood. 2018; 132(16):1657-1663. DOI: 10.1182/blood-2018-06-860882. View

Tremblay D, Sokol K, Bhalla S, Rampal R, Mascarenhas J . Implications of Mutation Profiling in Myeloid Malignancies-PART 1: Myelodysplastic Syndromes and Acute Myeloid Leukemia. Oncology (Williston Park). 2018; 32(4):e38-e44. View

Ley T, Miller C, Ding L, Raphael B, Mungall A, Robertson A . Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013; 368(22):2059-74. PMC: 3767041. DOI: 10.1056/NEJMoa1301689. View

Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik V, Paschka P, Roberts N . Genomic Classification and Prognosis in Acute Myeloid Leukemia. N Engl J Med. 2016; 374(23):2209-2221. PMC: 4979995. DOI: 10.1056/NEJMoa1516192. View

Steensma D . Myelodysplastic syndromes current treatment algorithm 2018. Blood Cancer J. 2018; 8(5):47. PMC: 5967332. DOI: 10.1038/s41408-018-0085-4. View

Foran J . Do cytogenetics affect the post-remission strategy for older patients with AML in CR1?. Best Pract Res Clin Haematol. 2017; 30(4):306-311. DOI: 10.1016/j.beha.2017.09.008. View

Arber D, Orazi A, Hasserjian R, Thiele J, Borowitz M, Le Beau M . The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016; 127(20):2391-405. DOI: 10.1182/blood-2016-03-643544. View

10.

Ogawa S . Genetics of MDS. Blood. 2019; 133(10):1049-1059. PMC: 6587668. DOI: 10.1182/blood-2018-10-844621. View

11.

Naoe T, Kiyoi H . Gene mutations of acute myeloid leukemia in the genome era. Int J Hematol. 2013; 97(2):165-74. DOI: 10.1007/s12185-013-1257-4. View